From the beginning of the year, Grey Delhi has been handling the creative duties for Crocin in India. The development is following GlaxoSmithKline's appointment of Grey to handle the global creative duties for Panadol (Crocin in India) in September 2010. In India and in some other international markets, the creative duties were handled by Ogilvy & Mather.
When contacted, GSK officials confirmed the development but declined to comment on the same.
Confirming the developments, Ketan Desai, associate vice president and branch head, Grey Delhi, said, "We got the account as part of the global realignment, and will be servicing the business out of Delhi. For servicing the account, we are are in the process of setting up a dedicated team which will be operational from February 1."
.png&h=334&w=500&q=100&v=20170226&c=1)
.png&h=268&w=401&q=100&v=20170226&c=1)
.png&h=268&w=401&q=100&v=20170226&c=1)
